Q2 earnings of IBN Sina increase by 21%
BI Report || BusinessInsider
IBN Sina Pharmaceutical Industry Limited logo
IBN Sina Pharmaceutical Industry Limited has posted a 21-percent increase in its earnings in the second quarter ended on December 31, 2021 as against the same quarter last year.
Its earnings per share (EPS) stood at Tk 5.97 in the Q2, up from Tk 4.95 recorded in the same period a year earlier, said the company in a filing with the Dhaka Stock Exchange on Sunday.
As of December 31, 2021, the company’s net asset value (NAV) per share stood at Tk 74.49 against Tk 68.69 as on June 30, 2021.
Meanwhile, the company had consolidated earnings per share (EPS) of Tk 10.49 in the first six months of the current financial year (July-December ’21).
The EPS for the same period of the previous financial year was Tk 8.19. As a result, the company’s profit has increased by Tk 2.30 or 28 percent.